Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Rep ; 49(11): 11193-11199, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36104585

ABSTRACT

Rheumatoid arthritis (RA) is a chronic inflammatory disease of autoimmune origin with many associated genetic traits, including genes related to the control of inflammation. The A20 protein, encoded by the TNFAIP3 gene, is a negative regulator of NF-kB mediated inflammation. Several single nucleotide variants (SNVs) of TNFAIP3 are associated with susceptibility to RA in different ethnic groups, none of which has been evaluated in Mexican patients. OBJECTIVE: To examine the possible association of eight TNFAIP3 SNVs in Mexican patients with RA. MATERIALS: We studied 471 patients with RA and 500 controls, as well as eight TNFAIP3 SNVs: including, rs10499194C/T, rs6920220G/A, and rs2230926T/G, which have been associated with RA in European or Asian patients, in addition to rs373421182G/C, rs139054966T/G, rs5029924C/T, rs59693083A/G and rs61593413T/A, not previously examined in RA. All SNVs were evaluated by means of an allelic discrimination assay using TaqMan probes. RESULTS: The allelic and genotypic frequencies of all SNVs examined were similar between cases and controls, and none of them was associated with RA under the allelic, codominant, dominant, and recessive models, as well as in haplotype combinations. CONCLUSION: Our data indicate that TNFAIP3 SNVs evaluated herein are not risk factors for RA in Mexican subjects.


Subject(s)
Arthritis, Rheumatoid , Genetic Predisposition to Disease , Humans , Polymorphism, Single Nucleotide/genetics , Nuclear Proteins/genetics , Intracellular Signaling Peptides and Proteins/genetics , DNA-Binding Proteins/genetics , Case-Control Studies , Arthritis, Rheumatoid/genetics , Genotype , Inflammation , Nucleotides , Tumor Necrosis Factor alpha-Induced Protein 3/genetics
2.
Sci Rep ; 6: 28415, 2016 06 23.
Article in English | MEDLINE | ID: mdl-27335086

ABSTRACT

During the transition from a healthy state to a cancerous one, cells alter their metabolism to increase proliferation. The underlying metabolic alterations may be caused by a variety of different regulatory events on the transcriptional or post-transcriptional level whose identification contributes to the rational design of therapeutic targets. We present a mechanistic strategy capable of inferring enzymatic regulation from intracellular metabolome measurements that is independent of the actual mechanism of regulation. Here, enzyme activities are expressed by the space of all feasible kinetic constants (k-cone) such that the alteration between two phenotypes is given by their corresponding kinetic spaces. Deriving an expression for the transformation of the healthy to the cancer k-cone we identified putative regulated enzymes between the HeLa and HaCaT cell lines. We show that only a few enzymatic activities change between those two cell lines and that this regulation does not depend on gene transcription but is instead post-transcriptional. Here, we identify phosphofructokinase as the major driver of proliferation in HeLa cells and suggest an optional regulatory program, associated with oxidative stress, that affects the activity of the pentose phosphate pathway.


Subject(s)
Enzymes/metabolism , Metabolome , Cell Line , Cell Proliferation , Electrophoresis, Capillary , Gene Expression Regulation , HeLa Cells , Humans , Kinetics , Mass Spectrometry , Phosphofructokinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...